Bangladesh · Delayed Price · Currency is BDT The ACME Laboratories Statistics
Total Valuation
DSE:ACMELAB has a market cap or net worth of BDT 16.82 billion. The enterprise value is 37.99 billion.
| Market Cap | 16.82B |
| Enterprise Value | 37.99B |
Important Dates
The next estimated earnings date is Thursday, October 15, 2026.
| Earnings Date | Oct 15, 2026 |
| Ex-Dividend Date | Nov 19, 2025 |
Share Statistics
DSE:ACMELAB has 211.60 million shares outstanding. The number of shares has increased by 0.00% in one year.
| Current Share Class | 211.60M |
| Shares Outstanding | 211.60M |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 34.86% |
| Owned by Institutions (%) | 7.51% |
| Float | 137.83M |
Valuation Ratios
The trailing PE ratio is 6.31.
| PE Ratio | 6.31 |
| Forward PE | n/a |
| PS Ratio | 0.42 |
| PB Ratio | 0.60 |
| P/TBV Ratio | 0.60 |
| P/FCF Ratio | 5.31 |
| P/OCF Ratio | 2.94 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.26, with an EV/FCF ratio of 12.00.
| EV / Earnings | 14.25 |
| EV / Sales | 0.95 |
| EV / EBITDA | 4.26 |
| EV / EBIT | 5.66 |
| EV / FCF | 12.00 |
Financial Position
The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.85.
| Current Ratio | 1.20 |
| Quick Ratio | 0.29 |
| Debt / Equity | 0.85 |
| Debt / EBITDA | 2.67 |
| Debt / FCF | 7.50 |
| Interest Coverage | 2.14 |
Financial Efficiency
Return on equity (ROE) is 9.86% and return on invested capital (ROIC) is 10.33%.
| Return on Equity (ROE) | 9.86% |
| Return on Assets (ROA) | 7.10% |
| Return on Invested Capital (ROIC) | 10.33% |
| Return on Capital Employed (ROCE) | 17.81% |
| Weighted Average Cost of Capital (WACC) | 7.71% |
| Revenue Per Employee | 4.44M |
| Profits Per Employee | 295,383 |
| Employee Count | 9,025 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 1.86 |
Taxes
In the past 12 months, DSE:ACMELAB has paid 906.27 million in taxes.
| Income Tax | 906.27M |
| Effective Tax Rate | 25.37% |
Stock Price Statistics
The stock price has increased by +12.45% in the last 52 weeks. The beta is 0.08, so DSE:ACMELAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | +12.45% |
| 50-Day Moving Average | 76.60 |
| 200-Day Moving Average | 76.21 |
| Relative Strength Index (RSI) | 57.06 |
| Average Volume (20 Days) | 489,495 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DSE:ACMELAB had revenue of BDT 40.05 billion and earned 2.67 billion in profits. Earnings per share was 12.60.
| Revenue | 40.05B |
| Gross Profit | 16.64B |
| Operating Income | 6.71B |
| Pretax Income | 3.57B |
| Net Income | 2.67B |
| EBITDA | 8.88B |
| EBIT | 6.71B |
| Earnings Per Share (EPS) | 12.60 |
Balance Sheet
The company has 2.59 billion in cash and 23.76 billion in debt, with a net cash position of -21.17 billion or -100.03 per share.
| Cash & Cash Equivalents | 2.59B |
| Total Debt | 23.76B |
| Net Cash | -21.17B |
| Net Cash Per Share | -100.03 |
| Equity (Book Value) | 27.99B |
| Book Value Per Share | 132.35 |
| Working Capital | 4.33B |
Cash Flow
In the last 12 months, operating cash flow was 5.72 billion and capital expenditures -2.56 billion, giving a free cash flow of 3.17 billion.
| Operating Cash Flow | 5.72B |
| Capital Expenditures | -2.56B |
| Depreciation & Amortization | 2.17B |
| Net Borrowing | -1.41B |
| Free Cash Flow | 3.17B |
| FCF Per Share | 14.97 |
Margins
Gross margin is 41.55%, with operating and profit margins of 16.75% and 6.66%.
| Gross Margin | 41.55% |
| Operating Margin | 16.75% |
| Pretax Margin | 8.92% |
| Profit Margin | 6.66% |
| EBITDA Margin | 22.17% |
| EBIT Margin | 16.75% |
| FCF Margin | 7.91% |
Dividends & Yields
This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 4.35%.
| Dividend Per Share | 3.50 |
| Dividend Yield | 4.35% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 27.80% |
| Buyback Yield | -0.00% |
| Shareholder Yield | 4.34% |
| Earnings Yield | 15.85% |
| FCF Yield | 18.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |